CCM Clinical Research Group
Miami, Florida 33186
4 studies enrolling now · 13 studies all time
What they study most
Agitation, Agitation in Participants With Dementia of the Alzheimer's Type, Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer Disease, Alzheimer's Disease, Alzheimer's Type Dementia, Attention Deficit Disorder (ADD), Attention Deficit Disorder With Hyperactivity (ADHD), Autism Spectrum Disorder (ASD), Bi-Polar Disorder, COVID-19, Early Alzheimer's Disease
Studies at this site
- Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3) — Recruiting now
- An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms — Recruiting now
- Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type — Recruiting now
- An Investigational Study Examining the Efficacy of QbMobile in Treatment Monitoring in Individuals With ADHD — Enrolling by invitation
- A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease — Running, not enrolling
- Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type — Stopped early
- A Study of S-892216 in Participants With COVID-19 — Completed
- Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment — Completed
- Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection — Completed
- PBI-0451 (Pomotrelvir) Phase 2 Study in Nonhospitalized Symptomatic Adults With COVID-19 — Stopped early
- SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study — Completed
- Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimer's Type — Completed
- A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite® — Stopped early